Galenica closes Bichsel: 170 jobs at risk (cross-border guide)

Di Valerie Linc · Published on

Pharmaceutical giant Galenica announces a major restructuring: closure of the Bichsel subsidiary due to low competitiveness. Costs of 40 million and an uncertain future for 170 employees.

Contesto

TL;DR - Galenica closes Bichsel subsidiary by year-end - 170 jobs at risk, restructuring costs 35-40M CHF - Focus shift to home care and Amavita network ## Key facts - Cosa: Chiusura della sussidiaria Bichsel - Quando: Entro la fine dell'anno - Dove: Svizzera, con impatto su Ticino - Chi: Galenica, operatore farmaceutico svizzero - Importo: Costi di ristrutturazione: 35-40 milioni CHF - Scadenza: Benefici EBIT attesi dal 2027 - Lavori a rischio: 170 posti di lavoro a rischio - Nuova strategia: Focalizzazione su assistenza domiciliare e rete Amavita News that is shaking the Swiss pharmaceutical sector, with potential repercussions for the Ticino job market as well. Galenica, a giant in medicine distribution and operator of the well-known Amavita and Sun Store pharmacy chains, has announced the closure of its Bichsel subsidiary by the end of the year. The reason, as stated in an official press release, is a "lack of competitiveness." The decision puts a significant 170 jobs at risk. A consultation process has been immediately initiated for the affected employees, a mandatory step in operations of this scale, but one that still leaves great uncertainty about their future. The restructuring is not painless for the group's finances: costs are estimated at between 35 and 40 million Swiss francs, which will weigh almost entirely on the first-half accounts. Of this, a substantial portion, between 17 and 19 million, is allocated to cover write-downs on stock and fixed assets. The plan involves a strategic reorganization: the subsidiary will in the future focus exclusively on providing home care services, a growing sector, while the historic Grosse Apotheke Dr. G. Bichsel in Interlaken, Canton of Bern, will be absorbed and integrated into the Amavita network. This move aims t...

Dettagli operativi

Although the announced layoffs do not directly affect Ticino, Galenica's operation is a warning bell for the entire healthcare and pharmaceutical sector, which employs a significant number of cross-border workers. The decision by such a dominant player is symptomatic of the competitive pressures and the need for consolidation that characterize the Swiss market. The "lack of competitiveness" cited by Galenica is not an isolated problem but reflects a national trend of cost optimization and the search for greater efficiency. ## Market Implications Galenica's move signals a clear strategic direction: divesting less profitable business lines to focus on two fronts: - Home Care: A rapidly expanding market, driven by an aging population and the desire to reduce hospital costs. - Consolidated pharmacy networks: Strengthening brands like Amavita indicates a desire to standardize the offering and leverage economies of scale. 📊 Financial Data of the Operation - Restructuring cost: 35-40 million CHF - Write-downs: 17-19 million CHF - Expected EBIT benefit: +3 million CHF/year from 2027 For workers in the sector, including the many cross-border commuters working in pharmacies, laboratories, or pharmaceutical companies in Ticino, this scenario underscores the growing importance of specialization and flexibility. The market transformation could create new opportunities in areas like home care, but at the same time increase pressure on more traditional roles. Monitoring these trends becomes essential for career guidance.

Punti chiave

What does this story teach those who work in Switzerland? That no job is guaranteed forever, not even in historically stable sectors like pharmaceuticals. Galenica's restructuring is a clear example of how global market dynamics and pressure on margins can lead to drastic decisions with a direct impact on employment. 💡 Practical Advice for Sector Workers - Continuous training: Investing in specialized skills, especially in emerging areas like digital health or home care, can make a difference. - Networking: Maintaining an active professional network is crucial for seizing new opportunities quickly. - Financial awareness: Thoroughly understanding one's own financial situation is the first step in facing periods of uncertainty. Events like this are a reminder of how crucial it is to have full control over one's finances. Knowing your exact net salary, after all deductions and contributions, allows for more serene future planning and a clear-headed assessment of any new job offers. For anyone wanting a clear picture of their payslip, our net salary calculator is an indispensable tool for conscious financial management. Source: Tio/Ats Awp, February 24, 2026

Punti chiave

[{"q":"Galenica closes branch in Switzerland, what happens to jobs?","a":"The closure of the Bichsel branch in Galenica by the end of the year puts about 170 jobs at risk. A consultation procedure has been launched for the employees involved, but the employment future is uncertain. The transaction aims at a strategic reorganization of the group."},{"q":"What are the costs of the renovation of Galenica?","a":"The renovation announced by Galenica will cost estimated between 35 and 40 million Swiss francs. Of these, a significant part (17-19 million) is destined to cover the devaluation of stocks and immobilizations, impacting the accounts of the first half of the year."},{"q":"Which sectors are upgrading Galenica after closing?","a":"Galenica intends to focus on providing home care (Home Care), a growing sector. In addition, it will strengthen its network of established pharmacies, such as Amavita and Sun Store, to optimize operations and exploit economies of scale."},{"q":"Does the closure of Bichsel also concern frontier workers in Ticino?","a":"Although the direct redundancies do not concern Ticino, Galenica's decision is a wake-up call for the health and pharmaceutical sectors. It reflects the competitive pressures and the need for cost optimisation that also affect cross-border workers."},{"q":"What do Swiss pharmaceutical workers do to adapt to changes?","a":"It is essential to invest in continuing training, specialising in emerging areas such as home care or digital health. Maintaining a network of active professional contacts and having a solid financial awareness are just as crucial to addressing market uncertainty."}]

Frequently Asked Questions
Galenica closes branch in Switzerland, what happens to jobs?
The closure of the Bichsel branch in Galenica by the end of the year puts about 170 jobs at risk. A consultation procedure has been launched for the employees involved, but the employment future is uncertain. The transaction aims at a strategic reorganization of the group.
What are the costs of the renovation of Galenica?
The renovation announced by Galenica will cost estimated between 35 and 40 million Swiss francs. Of these, a significant part (17-19 million) is destined to cover the devaluation of stocks and immobilizations, impacting the accounts of the first half of the year.
Which sectors are upgrading Galenica after closing?
Galenica intends to focus on providing home care (Home Care), a growing sector. In addition, it will strengthen its network of established pharmacies, such as Amavita and Sun Store, to optimize operations and exploit economies of scale.
Does the closure of Bichsel also concern frontier workers in Ticino?
Although the direct redundancies do not concern Ticino, Galenica's decision is a wake-up call for the health and pharmaceutical sectors. It reflects the competitive pressures and the need for cost optimisation that also affect cross-border workers.
What do Swiss pharmaceutical workers do to adapt to changes?
It is essential to invest in continuing training, specialising in emerging areas such as home care or digital health. Maintaining a network of active professional contacts and having a solid financial awareness are just as crucial to addressing market uncertainty.

Related articles